Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi019-A) from a patient with Charcot-Marie-Tooth disease type 2A2 (CMT2A2) due to a heterozygous missense substitution c.2119C > T (p.Arg707Trp) in MFN2 gene

Summary

Charcot-Marie-Tooth disease (CMT) is an inherited neurological disorder characterized by the progressive damage of the peripheral nerves. We generated a human induced pluripotent stem cell (iPSC) line JUCTCi019-A using dermal fibroblasts-derived from a 50-year-old CMT2A2 patient carrying a heterozygous missense substitution c.2119C > T (p.Arg707Trp) in the MFN2 gene. Fibroblasts were reprogrammed by Sendai viruses encoding for the reprogramming factors: OCT4, SOX2, KLF4 and c-MYC. Characterization showed normal iPSC morphology and karyotype, expression of pluripotency markers and differentiation into three-germ layers. This iPSC line represents an ideal source for disease modelling and drug development of CMT2A2 disease. Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Authors Ababneh NA, Barham R, Al-Kurdi B, Ali D, Hadidi SA, A Ismail M, Muamar ASH, Abdulelah AA, Madadha A, Sallam M, Hassona Y, Masri A, Awidi A
Journal Stem cell research
Publication Date 2022 Apr 12;62:102786
PubMed 35468369
DOI 10.1016/j.scr.2022.102786

Research Projects

Cell Lines